α2-Macroglobulin is a potential facilitator of prion protein transformation

Amyloid

Volumn 14, Issue 1, 2007, Pages 1-10

  Adler, Victor ^a   Davidowitz, Eliot ^a   Tamburi, Patricia ^a   Rojas, Pedro ^a   Grossman, Abraham ^a  

^a Q RNA Inc   (United States)

Author keywords

2 Macroglobulin; Prion; Proteinase K; PrPC; PrPres; PrPSc

Indexed keywords

ALPHA 2 MACROGLOBULIN; PRION PROTEIN; PROTEINASE; RNA; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN PURIFICATION; ANIMAL; ELECTRON MICROSCOPY; HAMSTER; ISOLATION AND PURIFICATION; METABOLISM; PRION; ULTRASTRUCTURE;

ALPHA-MACROGLOBULINS; ANIMALS; CRICETINAE; HUMANS; MICROSCOPY, ELECTRON; PRIONS; RECOMBINANT PROTEINS;

EID: 33947639976     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120600960452     Document Type: Article

References (31)

1. DeArmond SJ, Pruisner SB. Perspectives on prion biology, prion disease pathognesis, and pharmacologic approaches to treatment. Clin Lab Med 2003;23:1-41.
2. Priola SA, Vorberg I. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Methods Mol Biol 2004;268:517-540.
3. Weissmann C, Flechsig E. PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 2003;66:43-60.
4. Legname G, Baskakov IV, Nguyen HO, Riesner, D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004;305:673-676.
5. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995;83:79-90.
6. Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med 2004;10:S63-67.
7. Croes EA, Theuns J, Houwing-Duistermaat JJ, Dermaut B, Sleegers K, Roks G, van den Broek M, van Harten B, van Swieten JC, Cruts M, van Broeckhoven C, van Duijn CM. Octapeptide repeat insertions in the prion protein gene and early onset dementia. J Neurol Neurosurg Psychiatry 2004;75:1166-1170.
8. Manuelidis L. Transmissible encephalopathies: speculations and realities. Viral Immunol 2003;16:123-139.
9. Adler V, Zeiler B, Kryukov V, Kascak R, Rubenstein R, Grossman A. Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J Mol Biol 2003;332:47-57.
10. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003;6:717-720.
11. Nandi PK, Nicole JC. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent. J Mol Biol 2004;344:827-837.
12. Zeiler B, Adler V, Kryukov V, Grossman A. Concentration and removal of prion proteins from biological solutions. Biotechnol Appl Biochem 2003;37:173-182.
13. Pan KM, Stahl N, Prusiner SB. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1992;1:1343-1352.
14. Hiraoka A, Tominaga I, Hori K. Sodium dodecylsulfate capillary gel electrophoretic measurement of the concentration ratios of albumin and alpha2-macroglobulin in cerebrospinal fluid and serum of patients with neurological disorders. J Chromatogr A 2000;895:339-344.
15. Swenson RP, Howard JB. Structural characterization of human alpha2-macroglobulin subunits. J Biol Chem 1979;254:4452-4456.
16. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;115:3719-3727.
17. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982;218:1309-1311.
18. Pan KM, Stahl N, Prusiner SB. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci 1992;1:1343-1352.
19. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue T, Craig WY. Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004;18:139-147.
20. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, Anderson RG, Taraboulos A, Prusiner SB. Proc Natl Acad Sci USA 1996;93:14945-14949.
21. Li R, Liu D, Zanusso G, Liu T, Fayen JD, Huang JH, Petersen RB, Gambetti P, Sy MS. The expression and potential function of cellular prion protein in human lymphocytes. Cell Immunol 2001;207:49-58.
22. Simak J, Holada K, D'Agnillo F, Janota J, Vostal JG. Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 2002;42:334-342.
23. Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J 2005;385:831-838.
24. Kaminishi H, Miyaguchi H, Tamaki T, Suenaga N, Hisamatsu M, Mihashi I, Matsumoto H, Maeda H, Hagihara Y. Degradation of humoral host defense by Candida albicans proteinase. Infect Immun 1995;63:984-988.
25. Vasan S, Mong PY, Grossman A. Interaction of prion protein with small highly structured RNAs: detection and chacterization of PrP-oligomers. Neurochem Res 2006;31:629-637.
26. DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc Natl Acad Sci USA 1997;94:13938-13943.
27. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, Riesner D. Search for a prion-specific nucleic acid. J Virol 2005;79(16):10796-10806.
28. Sc-like conformation in the cytosol. Science 2002;298(5599):1785- 1788.
29. C. Neurosci Lett 2005;374:98-103.
30. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE and Glabe CG. Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004;279:46363-46366.
31. Saunders AJ, Tanzi RE. Welcome to the complex disease world: Alpha2-macroglobulin and Alzheimer's disease. Exp Neurol 2003;184:50-53.